NCT05070039View on ClinicalTrials.gov

Value of Cortactin Expression in Invasive and Non-invasive Urinary Bladder Urothelial Carcinoma in Egyptian Population

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

December 30, 2021

Study Completion Date

January 1, 2022

Conditions
Urothelial Carcinoma
Interventions
GENETIC

Expression of Cortactin anti body

assessment of Cortactin immunohistochemical expression in invasive and non-invasive urothelial carcinoma.

Trial Locations (1)

82524

Maisa Hashem Mohammed, Sohag

All Listed Sponsors
lead

Sohag University

OTHER